Thermo Fisher Scientific 

€543.2
1065
-€7.1-1.29% Friday 12:09

统计数据

当日最高
548.8
当日最低
543.2
52周最高
-
52周最低
-
成交量
20
平均成交量
-
市值
227.74B
市盈率
36.61
股息收益率
0.26%
股息
1.41

即将到来

股息

0.26%股息收益率
10年增长
10.03%
5年增长
15.47%
3年增长
14.47%
1年增长
11.43%

收益

23Oct已确认
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一个
4.71
5.04
5.36
5.69
预期每股收益
5.260376
实际每股收益
N/A

人们还关注

此列表基于关注TN8.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。
Danaher
DHR
市值193.63B
Danaher Corporation 在生命科学和诊断等类似领域运营,与 Thermo Fisher 在产品提供和市场份额上是直接竞争对手。
Bio-Rad Laboratories
BIO
市值9.07B
Bio-Rad Laboratories, Inc.为生命科学研究和临床诊断市场提供一系列产品,直接与Thermo Fisher的产品线竞争。
Agilent Technologies
A
市值39.94B
Agilent Technologies, Inc. 提供仪器、服务、耗材、应用和专业知识,重点关注生命科学、诊断和应用化学市场,与 Thermo Fisher 的产品有很大的重叠。
Waters
WAT
市值19.75B
Waters Corporation专注于生命科学的分析仪器,使其成为实验室设备和耗材市场上的竞争对手。
Bruker
BRKR
市值9.01B
Bruker Corporation 设计和制造科学仪器以及分析和诊断解决方案,用于与 Thermo Fisher 类似的客户群体。
Mettler-Toledo International
MTD
市值29.65B
Mettler-Toledo International Inc. 以其精密仪器和专业服务而闻名,包括在生命科学领域,使其成为实验室设备市场上的竞争对手。
Resmed
RMD
市值31.82B
ResMed Inc. 专门开发、制造和营销用于诊断、治疗和管理呼吸系统疾病的医疗设备和基于云的软件应用程序,在医疗保健和诊断领域与赛默飞世尔科技间接竞争。
Illumina
ILMN
市值19.68B
Illumina, Inc.专注于基因和基因组分析的测序和基于阵列的解决方案,与Thermo Fisher在基因组学和分子诊断市场竞争。
Baxter International
BAX
市值18.95B
Baxter International Inc. 提供广泛的基本医疗保健产品,包括医疗设备、药品和生物技术,使其成为更广泛的医疗保健竞争对手。

分析师评级

636.08平均价格目标
最高估值为 €670。
来自过去6个月内的 13 个评级。这不是投资建议。
买入
85%
持有
15%
卖出
0%

关于

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Show more...
首席执行官
Mr. Marc N. Casper
员工
122000
国家
US
ISIN
US8835561023
WKN
000857209

上市公司